** [Data provided: Nexon]


** \ – 1 day Google Play and Apple App Store Popular and Sales 1st place,

\ – Lee Jeong Heon Nexon “I will find the fun of the game that users think,”

Dungeon & Fighter Mobile - Gameplay (Android) | Official KR Launch

Korea’s representative game ‘Dungeon & Fighter’ wrote a new history again on mobile.

The ‘Dungeon & Fighter Mobile (Dungeon Baiye Bai) of Nexon Co., Ltd.’ was released on Google Play and Apple App Store on the first place in Google Play and Apple App Store.

Ahead, Dawn, has been on the first place for Apple App Store sales in 5 hours from 8:00 am on the 24th. Dictionary downloads 12 million cases, Dictionary characters generated by 1100 million users, and the number of users who have accessed the game on the day of launch is 1 million.

Du Neople Live Director said, “I did not set a goal for sales rankings, and I wanted to listen to a ‘fun’ as a one person who sent youth with a dungeon and fighter,” he said, “he said,” he said, I will do my best to do it. “

Lee Jeong Heon said, “To secure growth engines through the improvement of the body of Nexon, the Nexon Company’s employees have created a meaningful change,” I have created a meaningful change, “I have made a meaningful change.” I will focus on it. “

Nexon presents a coupon to get Ryan Cokes (1111 “to all users, commemorating the top of the two marketed market.

Dungeon & Fighter Mobile is a 2D action game that is a 2D action game that has been a 2D action game that is a 2D action game that is a manual manipulation, which was a ‘action pleasure’ and enjoyed a manual manipulation in the past entertainment room, and a journey of adventurers on the Arad continent that the beautiful legend and miserable war coexist.

Meanwhile, Nexon is the ‘Mobile Mobile, Mobilization (Mabinogi Mobile, Tales Weaver: Second Run)’, ‘Cart Rider: Drift, Arc Radars, Project Magnum, Project HP, Project D, DNF Duel (DUEL) ‘,’ ‘,’ the market ‘s Pando, the big MMORPG (HIT2, Project ER), and the keywords, etc., and spurs on super IP development.